Castalia Fernández, Radiation Oncology Specialist at GenesisCare, shared on X about a paper by Neil K. Vuppala et al. published in the Journal of Neurosurgery:
“SBRT reirradiation for spinal metastases is safe and effective, with durable local control and low toxicity. Study of 224 segments shows no myelopathy, with neural dose limits of BED3 75 Gy (above conus) or 106 Gy (below). More research needed.”
Title: Oncological outcomes and safety after spinal reirradiation with stereotactic body radiotherapy
Authors: Neil K. Vuppala, Michael C. LeCompte, Palak P. Patel, Anjali J. D’Amiano, Ali Bydon, Khaled Kebaish, Nicholas Theodore, Sang Hun Lee, Debraj Mukherjee, Binbin Wu, Lawrence Kleinberg, Daniel Lubelski, Kristin J. Redmond
You can read the Full Article in the Journal of Neurosurgery.
More posts featuring Castalia Fernández on OncoDaily.